Eur J Clin Invest 2010; 40 (10): 943–949 Abstract Background ABO‐incompatible (ABOi)
living donor liver transplantation (LDLT) in adult patients has been controversial because of …

Living-donor liver transplantation is an important component of all liver transplant programs
especially in those that care for the pediatric population. Over the last 30 years, innovations …

We evaluated the effects of rituximab prophylaxis on outcomes of ABO‐blood‐type‐
incompatible living donor liver transplantation (ABO‐I LDLT) in 381 adult patients in the …

Objective: To assess the incidence of biliary complications after right lobe living-donor liver
transplantation (LDLT) in patients undergoing duct-to-duct choledochocholedochostomy or …

Abstract The Japanese Liver Transplantation Society (JLTS) was established in 1980 in
order to characterize and follow trends in patient characteristics and graft survival among all …

Abstract ABO‐incompatible (ABO‐I) living donor liver transplantation (LDLT) has been
performed in Japan to overcome the organ shortage. Reported herein are the results of this …

ABO incompatibility is no longer considered a contraindication for adult living donor liver
transplantation (ALDLT) due to various strategies to overcome the ABO blood group barrier …

Abstract Background/Purpose The aims of this study were to characterize the features of the
biliary complications that occur after right‐lobe living‐donor liver transplantation (RL‐LDLT) …

Forty‐six pediatric patients who underwent living donor liver transplantation (LDLT) using
parental liver grafts for inheritable metabolic disorders (IMD) were evaluated to determine …

Antibody-mediated rejection (AMR) is a refractory rejection after ABO blood-type
incompatible (ABOi) or donor-specific antibody (DSA)-positive liver transplantation (LT) …